Diamyd Medical: Diamyd Receives FDA Approval To Initiate Clinical Study In Chronic Pain (Medical News Today)
Diamyd Medical (NASDAQ:DMYDY)(STO:DIAMB) announced that it has received approval from the U.S. FDA to initiate a Phase I study in chronic pain using NP2, the company's first drug candidate in its Nerve Targeting Drug Delivery System (NTDDS) gene therapy platform. NP2, developed by the company's U.S. subsidiary, Diamyd, Inc.

Siemens Receives FDA Approval For The VERSANT 440 Molecular System (Medical News Today)
Siemens Healthcare (http://www.siemens.com/diagnostics) announced that its VERSANT(TM) 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy.

Biotechnology Industry Seeks Passage Of Bill To Allow FDA Approval Of Generic Biotech Medications (Medical News Today)
The biotechnology industry, which for years has opposed bills that would allow FDA to approve generic versions of biotech medications, has made such legislation a priority for 2008, the AP/Raleigh News & Observer reports.